Trial Profile

Single dose bioequivalence study of epoetin zeta (Hospira) and Epogen in healthy subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Oct 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Epoetin zeta (Primary) ; Epoetin alfa
Indications Anaemia
Focus Pharmacodynamics; Pharmacokinetics
Sponsors Hospira

Most Recent Events

31 Mar 2015 New trial record
27 Mar 2015 Results published in Hospira media release.
27 Mar 2015 Results presented at the National Kidney Foundation (NKF) spring meeting, according to a Hospira media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com